These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S. Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683 [Abstract] [Full Text] [Related]
3. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy? Kim H, Beriwal S, Houser C, Huq MS. Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690 [Abstract] [Full Text] [Related]
4. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):901-11. PubMed ID: 15936576 [Abstract] [Full Text] [Related]
7. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Koom WS, Sohn DK, Kim JY, Kim JW, Shin KH, Yoon SM, Kim DY, Yoon M, Shin D, Park SY, Cho KH. Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1446-54. PubMed ID: 17482766 [Abstract] [Full Text] [Related]
18. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer. Beriwal S, Kim H, Heron DE, Selvaraj R. Technol Cancer Res Treat; 2006 Oct 01; 5(5):521-7. PubMed ID: 16981795 [Abstract] [Full Text] [Related]